Adi Gazdar
机构: Professor of Pathology, UT Southwestern Medical Center
每年引用次数
引用次数
引用: 159,245
H-指数: 194
I10-指数 : 758
出版物: 1,335
Heterogeneity of Small Cell Lung-cancer (sclc) Cell-lines As Defined By Monoclonal-antibodies (moab)
F. Cuttitta , Af. Gazdar , Hk. Oie , Jd. Minna
American Association for Cancer Research. Proceedings of the Annual Meeting 26 297 -297
1985
Molecular Pathology of Early Cancer
Sudhir Srivastava , Donald Earl Henson , Adi F Gazdar ,
Melanoma Research 9 ( 4) 419
59
1999
Molecular analysis of the von Hippel-Lindau disease tumor suppressor gene in human lung cancer cell lines.
A. F. Gazdar , J. R. Gnarra , W. M. Linehan , B. Zbar
Oncogene 9 ( 6) 1599 -1604
90
1994
Elements of the rabbit uteroglobin promoter mediating its transcription in epithelial cells from the endometrium and lung.
M. Beato , G. Suske , W. Lorenz , J. Klug
Gene Expression 2 ( 4) 339 -352
19
1992
Seven-week continuous-infusion paclitaxel plus concurrent radiation therapy for locally advanced non-small cell lung cancer: A phase I study
D. I. Rosenthal , D. P. Carbone , O. Okani , A. F. Gazdar
Seminars in Oncology 24 ( 4)
12
1997
Gastrin-releasing peptide and other autocrine growth factors in lung cancer: pathogenetic and treatment implications.
J. D. Minna , F. Cuttitta , A. F. Gazdar , J. Trepel
Important advances in oncology 55 -64
13
1988
Association between histological type and neuroendocrine differentiation on drug sensitivity of lung cancer cell lines.
G. Giaccone , A. F. Gazdar , D. Venzon , D. C. Ihde
Journal of The National Cancer Institute Monographs ( 13) 191 -196
31
1992
Cytogenetic abnormalities in patients with cutaneous T-cell lymphomas.
A. F. Gazdar , M. J. Matthews , T. Knutsen , G. P. Schechter
Cancer treatment reports 63 ( 4) 575 -580
42
1979
Cell type-specific differences in metabolic activation of N-nitrosodiethylamine by human lung cancer cell lines.
Miriam Falzon , H. M. Schuller , A. F. Gazdar , T. Hegedus
IARC scientific publications ( 84) 138 -140
7
1987
Automated fluorescent analysis for drug-induced cytotoxicity assays.
A. F. Gazdar , J. C. Ruckdeschel , P. B. Jewett , H. Agren
Cancer treatment reports 70 ( 10) 1147 -1151
9
1986
TELOMERASE AND LUNG CANCER
A. F. Gazdar , A. Rathi , N. Onuki , Y. Kazuo
Lung biology in health and disease 124 269 -277
1
1999
Chromosomal deletion, gene amplification, alternative processing, and autocrine growth factor production in the pathogenesis of human lung cancer.
M. Birrer , J. D. Minna , F. Cuttitta , A. F. Gazdar
Princess Takamatsu symposia 17 109 -122
4
1986
myc family DNA amplification in tumors and tumor cell lines from patients with small-cell lung cancer.
A. F. Gazdar , D. C. Ihde , B. E. Johnson , J. F. Brennan
Journal of The National Cancer Institute Monographs 1992 ( 13) 39 -43
22
1992
Phase I studies of continuous-infusion paclitaxel given with standard aggressive radiation therapy for locally advanced solid tumors
D. Mendelsohn , K. Y. Orr , David Rosenthal , J. Truelson
Seminars in Oncology 22 ( 4) 13 -17
11
1995
Pathobiology of lung cancers
E. M. Mcdowell , A. F. Gazdar
Lung biology in health and disease 37 1 -42
14
1988
Cell surface protein phenotype delineates the lineage of cultured human variant small cell lung cancer (SCCL-V)
A. F. Gazdar , S. B. Baylin , D. N. Carney
Proceedings of the American Association for Cancer Research 26
1985
Establishment and characterization of a large comprehensive panel of cell lines demonstrates the diversity of human lung cancer
A. F. Gazdar , E. Russell , H. Oie
4
1985
Differential metabolism of n-nitrosodiethylamine (DEN) in human lung cancer cell lines (HLCCL)
A. F. Gazdar , Miriam Falzon , J. B. McMahon
1985
In vitro chemosensitivity of clinical specimens (CS) and established cell lines (CL) of small cell lung cancer (SCLC)
A. F. Gazdar , D. N. Carney , J. D. Minna
Stem Cells 1
3
1981
Erratum: (The Journal of Clinical Investigation (October 1997) 100:8 (2133-2137))
Ignacio Ivan Wistuba , Y. E. Miller , J. Haney , A. F. Gazdar
Journal of Clinical Investigation 100 ( 10)
1997